Columbia University

Technology Ventures

Latest News

Applied Therapeutics Inc., today announced the closing of its Series A financing round. The financing was led by Alexandria Venture Investments alongside E Squared Capital Management, Franklin Berger, ETP Global Fund and Syno Capital. Joel S.

Doctor Rebecca Brachman has been selected as a TED Fellow, joining a class of 15 change-makers from around the world who will deliver a talk on the TED stage this April in Vancouver.

Lin Bioscience and Columbia Technology Ventures announced that Lin Bioscience has licensed the intellectual property portfolio and development program for a promising first-in-class medication intended to slow or halt the progression of atrophic "Dry" Age-Related Macular Degeneration (AMD).  

Fortress Biotech, Inc. announced the formation of a new subsidiary company, Caelum Biosciences, Inc., to advance the development of CAEL‐ 101 (11‐1F4) for the treatment of amyloid light chain (“AL”) amyloidosis.

Mannheim/Wetzlar, Germany. Leica Microsystems CMS GmbH has entered into an exclusive, worldwide licensing agreement with Columbia University in New York to commercialize SCAPE microscopy for Life Science applications.

The sophisticated attack on Ukraine’s power grid last year plunged 225,000 people into darkness for days, and put America’s own aging, sprawling system under the spotlight.
Yuan Yang, assistant professor of materials science and engineering at Columbia Engineering, has developed a new method to increase the energy density of lithium (Li-ion) batteries.
Symbiote technology, which protects printers, routers, phones, and other peripherals from malware attacks, has been named by Popular Science as one of 2016’s “Best of What’s New.”
Balance is an essential component of daily life, something many of us take for granted. But not everyone can. In the United States alone, there are about 300,000 people living with spinal cord injury (SCI) and some 12,000 new SCI cases each year, most of them young adults, 80% of them men.